// Lizzia Raffaghello 1 , Angelo Vacca 2 , Vito Pistoia 1 , Domenico Ribatti 3 1 Laboratorio di Oncologia, Istituto G. Gaslini, Genova, Italy 2 Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy 3 Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy, National Cancer Institute “Giovanni Paolo II”, Bari, Italy Correspondence to: Domenico Ribatti, e-mail: domenico.ribatti@uniba.it Keywords: cancer associated fibroblasts, mesenchymal stromal cells, hematological malignancies, tumor microenvironment Received: September 03, 2014 Accepted: October 27, 2014 Published: December 06, 2014 ABSTRACT Tumor microenvironment plays an important role in cancer initiation and progression. In hematological malignancies, the bone marrow represents the paradigmatic anatomical site in which tumor microenvironment expresses its morphofunctional features. Among the cells participating in the composition of this microenvironment, cancer associated fibrobasts (CAFs) have received less attention in hematopoietic tumors compared to solid cancers. In this review article, we discuss the involvement of CAFs in progression of hematological malignancies and the potential targeting of CAFs in a therapeutic perspective.
No takes yet. Share an insight, caveat, or question.
Raffaghello et al. (2014) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: